Recombinant Human Relaxin-2 (B-33/A-24) Protein, CF 3596-RN-025/CF from R&D Systems, a Bio-Techne Brand | Biocompare.com

Be the first to write a review!

Citations:

Supplier Page from
R&D Systems, a Bio-Techne Brand for
Recombinant Human Relaxin-2 (B-33/A-24) Protein, CF

Description

Replaces 2804-RN/CF

Product Specs
ItemRecombinant Human Relaxin-2 (B-33/A-24) Protein, CF
CompanyR&D Systems, a Bio-Techne Brand
Price $449.00Supplier Page View Company Product Page
Catalog Number3596-RN-025/CF
FormatLyophilized from a 0.2 µm filtered solution in Acetonitrile and TFA
Size25 ug
Molecule NameRelaxin-2
Purity>97%, by SDS-PAGE under reducing conditions and visualized by silver stain
Molecular Weight2.7 kDa (A chain), 3.9 kDa (B chain)
ApplicationsBioactivity
Conjugate/TagUnconjugated
Source/Expression SystemE. coli-derived Recombinant Human Relaxin-2 (B-33/A-24) Protein, CF
StorageUse a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 °C as supplied. 1 month, 2 to 8 °C under sterile conditions after reconstitution. 3 months, -20 to -70 °C under sterile conditions after reconstitution
NCBI Gene AliasesH2, H2-RLX, bA12D24.1.2, bA12D24.1.1, RLXH2
NCBI Full Gene Namerelaxin 2
SpeciesHuman

Add to Compare List

R&D Systems, a Bio-Techne Brand

614 McKinley Place N.E.

Minneapolis, Minnesota 55413

United States

Phone: 1 (800) 343-7475
1 (612) 379-2956

Fax: 1 (612) 656-4400

Company Profile

Website: http://www.rndsystems.com

(1) Human Relaxin-2 Fusion Protein Treatment Prevents and Reverses Isoproterenol-Induced Hypertrophy and Fibrosis in Mouse HeartJournal of the American Heart AssociationDecember 17, 2019Sun J, Hao W, Fillmore N, Ma H, Springer D, Yu ZX, Sadowska A, Garcia A, Chen R, Muniz-Medina V, et al.

(2) Human relaxin-2 attenuates hepatic steatosis and fibrosis in mice with non-alcoholic fatty liver diseaseLaboratory investigation; a journal of technical methods and pathologyJuly 1, 2019Lee KC, Hsieh YC, Chan CC, Sun HJ, Huang YH, Hou MC, Lin HC.

(3) Relaxin 2 carried by magnetically directed liposomes accelerates rat midpalatal suture expansion and subsequent new bone formationBone reportsJune 1, 2019Kamimoto H, Kobayashi Y, Moriyama K.

(4) Identification of retinoic acid in a high content screen for agents that overcome the anti-myogenic effect of TGF-beta-1PloS oneNovember 30, 2010Krueger C, Hoffmann FM.

Be the First to Write a Review!